Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens-Reference-Cited by-同舟云学术

Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens

Published:2020-06-03 Issue:6 Volume:15 Page:e0234119
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hara Toshinori^ORCID,Suzuki Hiromichi,Oyanagi Tadatomo,Koyanagi Norito,Ushiki Akihito,Kawabata Naoki,Goto Miki,Hida Yukio,Yaguchi Yuji,Tamai Kiyoko,Notake Shigeyuki,Kawashima Yosuke,Sugiyama Akio,Uemura Keiichi,Kashiyama Seiya,Nanmoku Toru,Suzuki Satoshi,Yamazaki Hiroshi,Kimura Hideki,Kunishima Hiroyuki,Ohge Hiroki

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Clostridium difficile infection;JD Stanley;Curr Probl Surg,2013

2. Multicenter study of Clostridium difficile infection rates from 2000 to 2006;ER Dubberke;Infect Control Hosp Epidemiol,2010

3. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID);K Davies;Eur J Clin Microbiol Infect Dis,2016

4. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study;H Kato;Anaerobe,2019

5. The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review;TV Riley;Infect Dis Ther,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a mobile laboratory system in hydrogen fuel cell buses and evaluation of the performance for COVID-19 RT-PCR testing;Scientific Reports;2023-10-16

2. The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol;PLOS ONE;2021-12-31

3. Evaluation of GENECUBE® HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol;2021-08-26

4. A Prospective Evaluation of the Analytical Performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B;Molecular Diagnosis & Therapy;2021-05-18

5. A prospective evaluation of the analytical performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B;2021-02-25